Blockchain startup MediConnect has completed the workflow for the Proof-of-Concept (PoC) designed to track medications through the supply chain and begun integration of online pharmacy UK Meds’ processes to its platform.
Per a press release shared with on Sept. 26, MediConnect established a foundation and methodology for proof of concept finalization, which will enable tracking and managing of prescription medication through the supply chain — from manufacturer to end users.
In 2020, MediConnect is also planning to complete a pilot scheme, which includes up to 10 participants. As part of the pilot, MediConnect will integrate online pharmacy UK Meds’ processes into its blockchain-based platform, allowing thus to trace products through its supply chain and prevent the misuse of prescription medications.
Earlier this year, the Ugandan government partnered with MediConnect to trace counterfeit drugs in the country. Similar to UK Meds’ case, the blockchain-based platform enables the recording of prescription medication, thus identifying counterfeit drugs and preventing their distribution in the pharmaceutical supply chain.
The potential of blockchain tech in the healthcare and supply chain sectors is recognized by other world’s governments and institutions. Most recently, the United Arab Emirates’ Ministry of Health and Prevention launched a blockchain system for recording and sharing healthcare data.
Tech startup Nebula Genomics rolled out anonymous genetic testing earlier in September, enabling clients to purchase whole genome sequencing and provide saliva samples without the need to share personal data such as their name, address or credit card number.